Bristol Myers Squibb BMY Defensive Value Play Emerges Amid Low Volatility and Attractive Dividend Yield WVVIP Willamette reports Q1 2024 022 per share loss as stock gains 364 percent US Institutional and Governance Risk Assessment 2026 VDem Democracy Report Analysis